These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 12678232
21. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests. Gommer AM. Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952 [Abstract] [Full Text] [Related]
22. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test. van der Ark A, van Straaten-van de Kappelle I, Olander RM, Enssle K, Jadhav S, van de Donk H, Hendriksen C. Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617 [Abstract] [Full Text] [Related]
23. Development of an in vitro potency test for tetanus vaccines: an immunoassay based on Hc fragment determination. Prieur S, Broc S, Gal M, Poirier B, Fuchs F. Dev Biol (Basel); 2002 Jun; 111():37-46. PubMed ID: 12678223 [Abstract] [Full Text] [Related]
24. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation. Sesardic D, Winsnes R, Rigsby P, Behr-Gross ME. Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263 [Abstract] [Full Text] [Related]
25. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1. Cussler K, Rosskopf-Streicher U, Volkers P, Milne C. Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102 [Abstract] [Full Text] [Related]
26. Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed. Tierney R, Stickings P, Hockley J, Rigsby P, Iwaki M, Sesardic D. Biologicals; 2011 Nov; 39(6):404-16. PubMed ID: 21985899 [Abstract] [Full Text] [Related]
27. Three Rs potential in the development and quality control of immunobiologicals. Halder M. ALTEX; 2001 Nov; 18 Suppl 1():13-47. PubMed ID: 11854853 [Abstract] [Full Text] [Related]
28. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Hendrikson CF, Woltjes J, Akkermans AM, van der Gun JW, Marsman FR, Verschure MH, Veldman K. Dev Biol Stand; 1996 Nov; 86():335. PubMed ID: 8785975 [No Abstract] [Full Text] [Related]
29. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines. von Hunolstein C, Gomez Miguel MJ, Pezzella C, Scopetti F, Behr-Gross ME, Halder M, Hoffmann S, Levels L, van der Gun J, Hendriksen C. Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977 [Abstract] [Full Text] [Related]
30. Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin. Ebert E, Abu Karim A, Kayser T, Wenig R, Weibetaer K, Wirz M, Pisani G, Schäffner G, Cubetaler K. ALTEX; 1998 Dec; 15(5):30-32. PubMed ID: 11178535 [Abstract] [Full Text] [Related]
31. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines. Coombes L, Stickings P, Tierney R, Rigsby P, Sesardic D. J Immunol Methods; 2009 Oct 31; 350(1-2):142-9. PubMed ID: 19761770 [Abstract] [Full Text] [Related]
32. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human). Hendriksen C, van der Gun J, Winsnes R, Urdal T, Rautmann G, Esposito-Farese ME. Pharmeuropa Spec Issue Biol; 2001 Aug 31; 2001(1):7-11. PubMed ID: 11705101 [No Abstract] [Full Text] [Related]
33. Correlation between ToBI test and in vivo titration for diphtheria and tetanus. Quintilio W, Kapronezai J, Alessandro de Freitas F. Biologicals; 2015 Jan 31; 43(1):55-61. PubMed ID: 25458473 [Abstract] [Full Text] [Related]
34. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation. Rosskopf-Streicher U, Johannes S, Gyra H, Beckmann R, Cussler K. Dev Biol (Basel); 2002 Jan 31; 111():153-8. PubMed ID: 12678235 [Abstract] [Full Text] [Related]
35. Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in mice. Finco-Kent DL, Galvin JE, Suiter BT, Huether MJ. Biologicals; 2001 Mar 31; 29(1):7-10. PubMed ID: 11482887 [Abstract] [Full Text] [Related]
36. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay. Aggerbeck H, Heron I. Dev Biol Stand; 1996 Mar 31; 86():297-301. PubMed ID: 8785958 [Abstract] [Full Text] [Related]
37. Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative. Goris N, Willems T, Diev VI, Merkelbach-Peters P, Vanbinst T, Van der Stede Y, Kraft HP, Zakharov VM, Borisov VV, Nauwynck HJ, Haas B, De Clercq K. Vaccine; 2008 Jul 23; 26(31):3870-9. PubMed ID: 18555565 [Abstract] [Full Text] [Related]
38. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Rooijakkers E, Groen J, Uittenbogarrd J, van Herwijnen J, Osterhaus A. Dev Biol Stand; 1996 Jul 23; 86():137-45. PubMed ID: 8785943 [Abstract] [Full Text] [Related]
39. Determination of tetanus antitoxin levels in human immunoglobulins for intravenous use and in tetanus immunoglobulins by enzyme linked immunosorbent assay. Mainka C, Haase M. ALTEX; 1995 Jul 23; 12(1):24-30. PubMed ID: 11178413 [Abstract] [Full Text] [Related]
40. In vitro antigen ELISA for quality control of tetanus vaccines. Coombes L, Tierney R, Rigsby P, Sesardic D, Stickings P. Biologicals; 2012 Nov 23; 40(6):466-72. PubMed ID: 22898438 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]